Home
Scholarly Works
Retention of Triple Therapy With Methotrexate,...
Conference

Retention of Triple Therapy With Methotrexate, Sulfasalazine, and Hydroxychloroquine Compared to Combination Methotrexate and Leflunomide in Rheumatoid Arthritis, a Real-World Data From the Ontario Best Practices Research Initiative

Authors

Bhavsar S; Movahedi M; Cesta A; Pope J; Bombardier C

Volume

50

Pagination

pp. 35-36

Publisher

J RHEUMATOL PUBL CO

Publication Date

July 1, 2023

Conference proceedings

JOURNAL OF RHEUMATOLOGY

Issue

7

ISSN

0315-162X

Labels

Contact the Experts team